[1] Hanahan D,Weinberg R A. Hallmarks of cancer: The next generation. [J].Cell, 2011, 144(5):646-674.
[2] Siegel R L, Miller K D,Jemal A. Cancer statistics, 2017 [J].CA Cancer J Clin, 2017, 67(1):7-30.
[3] Williams D. Medical nanotechnology: how small can we go? [J].Med Device Technol,2002, 13(3):7-9.
[4] Moore A. Brave small world. Biotechnology and nanotechnology may give rise to a completely new industry [J].Embo Rep,2001, 2(2):86-88.
[5] Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. [J].Clin Cancer Res,2008, 14(5):1310-1316.
[6] Shi J, Kantoff P W, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. [J].Nat Rev Cancer,2017, 17(1):20-37.
[7] Kobayashi H, Watanabe R,Choyke P L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? [J].Theranostics,2013, 4(1):81-89.
[8] Smith AD. Big Moment for Nanotech: Oncology Therapeutics Poised for a Leap. Onclive.
[9] US National Library of Medicine. ClinicalTrials.gov. 2016.
[10] US National Library of Medicine. ClinicalTrials.gov. 2014.
[11] US National Library of Medicine. ClinicalTrials.gov. 2015.
[12] US National Library of Medicine. ClinicalTrials.gov. 2012.
[13] Barenholz Y. Doxil(R)--the first FDA-approved nano-drug: lessons learned[J].J Control Release,2012, 160(2):117-134.
[14] Petersen G H, Alzghari S K, Chee W, et al. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin [J].J Control Release,2016, 232:255-264.
[15] Gradishar W J, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer [J].J Clin Oncol,2005, 23(31):7794-7803.
[16] Kato K, Chin K, Yoshikawa T, et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer [J].Invest New Drugs,2012, 30(4):1621-1627.
[17] Maier H K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme [J].J Neurooncol, 2011, 103(2):317-324.